Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wen Li MD"'
Autor:
Yinlian Cai MD, Qianqian Zhang MD, Chen Gan MD, Jian Xu MD, Sheng Yu MD, Lingxue Tang MD, Senbang Yao MD, Wen Li MD, Runze Huang MD, Huaidong Cheng MD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 22 (2023)
Objective: To evaluate the effects of managing cancer and living meaningfully (CALM), a psychological intervention with semi-structured interviews, on cancer-related fatigue (CRF), quality of life (QOL), and sleep quality in patients with gastrointes
Externí odkaz:
https://doaj.org/article/b645e57919c94611b4156b8d6020360d
Autor:
Lian-Qiang Han MD, Chen-Huan Wang MM, Ting-Ting Cui MD, Fang Liu MD, Xiang-Dong Wang MD, Zi-Kai Wang MD, Wen Li MD, PhD
Publikováno v:
Cancer Control, Vol 29 (2022)
Background The purpose of this study was to explore the feasibility, safety and efficacy of iodine-125 seed implantation in the treatment of dysphagia of advanced esophageal cancer. Methods We retrospectively analyzed patients with advanced esophagea
Externí odkaz:
https://doaj.org/article/51256161168746adbb157a2dd116df64
Autor:
Senbang Yao MD, Ke Ding MD, Shaochun Liu MD, Qianqian Zhang MD, Wen Li MD, Lingxue Tang MD, Sheng Yu MD, Lulian Pang MD, Xiangxiang Yin MD, Huaidong Cheng MD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 21 (2022)
Background: The number of patients with breast cancer is increasing worldwide, resulting in a growing number of patients with chemotherapy-related cognitive impairment (CRCI), which seriously affects their quality of life. CRCI is associated with inf
Externí odkaz:
https://doaj.org/article/eb53f6e02d524cc88af170d47a92fc99
Autor:
Yu Li MD, Wen Li MD, Zhihui Wu MD, Jianhui Yuang PHD, Yanling Wei MD, Chao Huang MD, Daizheng Huang PHD
Publikováno v:
Inquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 59 (2022)
Aim: This study aimed to investigate the influencing factors of the medical-seeking behavior of patients in a hospital in Nanning and descriptively analyze the main factors to further improve the medical system and optimize the allocation of health r
Externí odkaz:
https://doaj.org/article/028ea335d2f4441d89df25aa325beaa9
Autor:
Ying Han, MD, Yinghui Yu, MD, Da Miao, MD, Mo Zhou, MD, Jing Zhao, MD, Zhehua Shao, MD, PhD, Rui Jin, MD, Xiuning Le, MD, PhD, Wen Li, MD, Yang Xia, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100630- (2024)
MET protooncogene (MET) alterations are known driver oncogenes in NSCLC. Since the identification of MET as a potential therapeutic target, extensive clinical trials have been performed. As a result, MET-targeted therapies, including MET tyrosine kin
Externí odkaz:
https://doaj.org/article/f365caa86a104535b08b63fe749c476a